Mr. Nicholas Sosiak reports

CANNARA ANNOUNCES GRADUATION TO THE TORONTO STOCK EXCHANGE

Cannara Biotech Inc. has received final approval to graduate from the TSX Venture Exchange to the Toronto Stock Exchange (the TSX).

"Graduating to the TSX represents a significant milestone in Cannara's evolution as a public company," said Zohar Krivorot, founder and chief executive officer of Cannara. "This achievement enhances our market visibility and liquidity while broadening our accessibility to institutional investors. It reflects the progress we have made as an organization and our commitment to building long-term shareholder value as we continue executing on our growth strategy."

In connection with the uplisting, the company's common shares will commence trading on the TSX at the opening of the market on March 2, 2026, under the trading symbol LOVE. Concurrently, the company's common shares will be delisted from the TSX-V effective March 2, 2026. To celebrate this milestone, Cannara will have the honour of opening the market at the TSX on March 17, 2026.

TD Cowen coverage initiation

The company is also pleased to announce that TD Cowen has initiated coverage on Cannara as of Feb. 24, 2026. TD Cowen's research report on Cannara is available through their platform. Please note that any opinions or forecasts regarding the company made by TD Cowen are theirs alone and neither represent the opinions or forecasts of Cannara or its management, nor imply that the company endorses or approves such information, conclusions or recommendations.

About Cannara Biotech Inc.

Cannara Biotech is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Quebec spanning over 1.6 million square feet, providing the company with 100,000 kilograms of potential annualized cultivation output. Leveraging Quebec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price.

We seek Safe Harbor.